Indication
Neurodegenerative Disease
10 clinical trials
9 products
1 drug
Product
SNK01Clinical trial
Single Center, Open Label, Phase 1 Study to Evaluate the Safety, Tolerability and Exploratory Efficacy of SNK01 in Subjects With Alzheimer's Disease (AD)Status: Terminated, Estimated PCD: 2023-08-16
Clinical trial
Positron Emission Tomography (PET) Imaging of Tau Pathology in Neurodegenerative DiseaseStatus: Recruiting, Estimated PCD: 2025-09-01
Product
18F-AV-1451Clinical trial
Safety and Pharmacokinetics of a Novel NMDA Receptor Antagonist Against Brain Related Diseases in Healthy Adult Volunteers: First-in-human, Phase I, Single Dose-escalating, Open Label StudyStatus: Withdrawn, Estimated PCD: 2024-05-02
Product
FluoroethylnormemantineClinical trial
A Natural History Study of Neurodegeneration and Optic Atrophy Caused by Ferredoxin Reductase Mutations in Pediatric and Adult PatientsStatus: Completed, Estimated PCD: 2023-08-17
Product
Mutation analysisClinical trial
A Natural History Study of Neurodegeneration and Optic Atrophy Caused by SLC25A46 Mutations in Pediatric and Adult PatientsStatus: Completed, Estimated PCD: 2023-08-17
Clinical trial
A Phase 2 Study to Assess the Safety and Efficacy of Cobimetinib in Refractory Langerhans Cell Histiocytosis, LCH-Associated Neurodegenerative Disease, and Other Histiocytic Disorders.Status: Recruiting, Estimated PCD: 2024-12-01
Product
CobimetinibClinical trial
Clinical Trial to Determine the Effects of Statins on Brain Health - STAREE-Mind Imaging SubstudyStatus: Active (not recruiting), Estimated PCD: 2026-09-01
Product
AtorvastatinDrug
VarlilumabClinical trial
Tocotrienols in Parkinson's Disease (PD): A Pilot, Randomised, Placebo-controlled TrialStatus: Recruiting, Estimated PCD: 2024-12-01
Product
Tocovid SuprabioClinical trial
Establishment of Genetic Basis for Neurological Disease by Genetic Screening and Development of Disease-specific Induced Pluripotent Stem (iPS) Cells From Dermal Fibroblasts in Selected PatientsStatus: , Estimated PCD: 2025-12-31
Product
Genechip screening kitClinical trial
Ferrochelating Treatment in Patients Affected by "Neurodegeneration With Brain Iron Accumulation" (NBIA)Status: Active (not recruiting), Estimated PCD: 2024-12-01
Product
Deferiprone